Amazing Cancer Cure Case Studies with Maitake Mushroom

Amazing cancer cure case studies with maitake mushroom has been clinically proven to prevent and heal cancer, as well as decrease and even eliminate cancerous tumors.

Maitake (grifola frondosa) is a polypore mushroom that is native to Japan. It grows in clusters at the base of trees, particularly oaks, and has been prized for its medicinal properties for centuries. It is commonly known as Hen of the Woods, Ram’s Head and Sheep’s Head, and its Japanese name, maitake, literally means “dancing mushroom,” a term derived from Japanese folk medicine.

Maitake is best known for its cancer-fighting properties. In 2009, a phase I/II human trial was conducted by Memorial Sloan-Kettering Cancer Center, and it showed that maitake extract stimulates the immune systems of breast cancer patients. The results of the study were published in the Journal of Cancer Research and Clinical Oncology.

Other laboratory studies involving Maitake D-Fraction (MDF), a standardized form of maitake mushroom containing grifolan — an important beta-glucan polysaccharide, show evidence of MDF’s therapeutic value. It exhibits anti-cancer activity, has the ability to block the growth of cancer tumors and boost the immune function of mice with cancer. maitake mushroom

A study published in the Townsend Letter for Doctors and Patients, Feb/Mar 1996 involving 165 individuals with advanced cancer used MDF. This form of maitake was found effective against leukemia as well as stomach and bone cancers.

A Japanese clinical study investigated the effectiveness of administering a combination of MDF and whole maitake powder on 36 cancer patients ranging in age from 22 to 57 years old, who were in stages II to IV. Cancer regression or significant symptom improvement was observed in 11 of 16 breast cancer patients (68.8%); 7 of 12 liver cancer patients (58.3%); and 5 of 8 lung cancer patients (62.5%).

Here are just a few of the amazing case studies that show the immune-potential effects of maitake in cancer patients.

Liver Tumor Disappears Completely

A 47-year-old female presented with Stage II hepatocellular carcinoma (cancer of the liver). In March 1994, she was treated with the drug cisplatin 4 times daily. In January 1995, she began taking maitake MD-fraction and 4 grams of whole maitake tablets daily, and the cisplatin treatment was discontinued. As of June 1997, the production of Interleukin-2 (IL-2) in her body multiplied by 2.2 times because of maitake administration. IL-2 is instrumental in the body’s natural response to microbial infection. By July 1999 the tumor had completely disappeared.

Lung Tumor Vanishes and Doesn’t Reappear

A 41-year-old female with Stage 3 intraductal carcinoma (breast cancer) had tumors that measured 2.4 cm and 0.7 cm in diameter. In September 1996, she underwent surgery to have the tumors removed, and she began taking 10 mg of tamoxifen (TAM) and 100 mg 5-FU until December 1996. As of June 1997, the cancer metastasized, and a 1.3 cm tumor was found in a lung.

She was then administered 125 mg MD-fraction and 4 grams whole maitake tablets daily for 20 months. In March 1999, it was confirmed that the lung tumor had disappeared. While taking maitake, IL-2 production and CD4+ cells (a type of white blood cell that is important in fighting infections) increased by 1.5 and 1.3 times, respectively. As of early 2002, the tumor had not reappeared.

Stage III Cancer Turns to Stage I

A 45-year-old female with Stage III liver cancer had a serum bilirubin of 3.2 mg/dL, albumin of 2.1 mg/dL, and prothrombin activation of 43 percent. In May 1995, she began receiving transcatheter arterial embolization (TAE) 10 mL lipiodol (iodized poppy seed oil), 15 mg ADM, and 100 mg cisplatin. That regimen was discontinued in January 1996 and was replaced by daily doses of 100 mg MD-fraction and 4 grams maitake tablets daily, along with 100 mg of the chemotherapy drug 5-fluorouracil (5-FU). Since February 1998 she has received only maitake products and is now diagnosed as Stage I.

Source: Can Maitake MD-Fraction Aid Cancer Patients? – Noriko Kodama, PhD, Kiyoshi Komuta, MD, PhD, and Hiroaki Nanba, PhD

Case histories such as those described above illustrate the immune-enhancing properties of MDF and whole powdered maitake. They also provide evidence that maitake has the potential to decrease the size of lung, breast and liver tumors.

Although maitake mushroom is best known for its anti-tumor, cancer-fighting properties, it also has the following properties:

Anti-Diabetic – People with Type 2 Diabetes have been found to benefit from maitake mushrooms. Maitake has the ability to lower blood sugar because it naturally contains an alpha glucosidase inhibitor. A specific, high-molecular polysaccharide called the X-fraction appears to be the active compound with anti-diabetic properties.

Anti-Hepatitis – In clinical trials with 32 chronic hepatitis B patients, there was a 72% recovery rate in the group that was administered maitake, as compared to 57% in the control group.

Anti-Hyperlipid – Many doctors in Japan use maitake mushrooms to: 1) lower serum and liver lipids (such as cholesterol, triglycerides, and phospholipids); and 2) regulate blood pressure — two key risk factors in heart disease.

Maitake mushrooms are eaten raw or cooked. Many people consume maitake as dietary supplements in the form of capsules and extracts called Maitake D-Fraction.